Suchergebnisse - (Person:"Spalluto, Giampiero")

PubPharm (183)

21

Functionalized ligands targeting G protein-coupled adenosine receptors

enthalten in: Future medicinal chemistry | 2019

von Federico, S. | Spalluto, G.

22

Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines to develop functionalized ligands to target adenosine receptors : fluorescent ligands as an example

enthalten in: MedChemComm | 2019

von Federico, S. | Margiotta, E. | Paoletta, S. | +6

23

A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition

enthalten in: ChemMedChem | 2019

von Redenti, S. | Marcovich, I. | De Vita, T. | +13

24

Structure Activity Relationship of 4-Amino-2-thiopyrimidine Derivatives as Platelet Aggregation Inhibitors

enthalten in: Medicinal chemistry (Shariqah (United Arab Emirates)) | 2019

von Cacciari, B. | Crepaldi, P. | Cheng, C. | +5

25

Structure Activity Relationship of 4-Amino-2-thiopyrimidine Derivatives as Platelet Aggregation Inhibitors

enthalten in: Medicinal chemistry | 2019

von Cacciari, B. | Crepaldi, P. | Cheng, C. | +5

26

Functionalized ligands targeting G protein-coupled adenosine receptors

enthalten in: Future medicinal chemistry | 2019

von Federico, S. | Spalluto, G.

27

Targeting Protein Kinase CK1δ with Riluzole : Could It Be One of the Possible Missing Bricks to Interpret Its Effect in the Treatment of ALS from a Molecular Point of View?

enthalten in: ChemMedChem | 2018

von Bissaro, M. | Federico, S. | Salmaso, V. | +3

28

1,2,4]Triazolo[1,5-c]pyrimidines as adenosine receptor antagonists : Modifications at the 8 position to reach selectivity towards A3 adenosine receptor subtype

enthalten in: European journal of medicinal chemistry | 2018

von Federico, S. | Margiotta, E. | Salmaso, V. | +5

29

A2A Adenosine Receptor Antagonists as Therapeutic Candidates : Are They Still an Interesting Challenge?

enthalten in: Mini reviews in medicinal chemistry | 2018

von Cacciari, B. | Spalluto, G. | Federico, S.

30

Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A2A and dopamine D2 receptors for Parkinson's disease treatment

enthalten in: PloS one | 2018

von Shao, Y. | Ma, X. | Paira, P. | +11